Literature DB >> 21948982

Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type.

Karine Crozat1, Samira Tamoutounour, Thien-Phong Vu Manh, Even Fossum, Hervé Luche, Laurence Ardouin, Martin Guilliams, Hiroaki Azukizawa, Bjarne Bogen, Bernard Malissen, Sandrine Henri, Marc Dalod.   

Abstract

Subsets of dendritic cells (DCs) have been described according to their functions and anatomical locations. Conventional DC subsets are defined by reciprocal expression of CD11b and CD8α in lymphoid tissues (LT), and of CD11b and CD103 in non-LT (NLT). Spleen CD8α(+) and dermal CD103(+) DCs share a high efficiency for Ag cross-presentation and a developmental dependency on specific transcription factors. However, it is not known whether all NLT-derived CD103(+) DCs and LT-resident CD8α(+) DCs are similar despite their different anatomical locations. XCR1 was previously described as exclusively expressed on mouse spleen CD8α(+) DCs and human blood BDCA3(+) DCs. In this article, we showed that LT-resident CD8α(+) DCs and NLT-derived CD103(+) DCs specifically express XCR1 and are characterized by a unique transcriptional fingerprint, irrespective of their tissue of origin. Therefore, CD8α(+) DCs and CD103(+) DCs belong to a common DC subset which is unequivocally identified by XCR1 expression throughout the body.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21948982     DOI: 10.4049/jimmunol.1101717

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  96 in total

1.  A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.

Authors:  Stephen T Ferris; Javier A Carrero; James F Mohan; Boris Calderon; Kenneth M Murphy; Emil R Unanue
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103- and XCR1+CD103+ dendritic cells.

Authors:  Ben Wylie; Elke Seppanen; Kun Xiao; Rachael Zemek; Damien Zanker; Sandro Prato; Bree Foley; Prue H Hart; Richard A Kroczek; Weisan Chen; Jason Waithman
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

3.  NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103+ dendritic cells.

Authors:  David Prescott; Charles Maisonneuve; Jitender Yadav; Stephen J Rubino; Stephen E Girardin; Dana J Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-29       Impact factor: 11.205

Review 4.  Tailored immunity by skin antigen-presenting cells.

Authors:  Clement Levin; Helene Perrin; Behazine Combadiere
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 5.  The role of chemokines in cutaneous immunosurveillance.

Authors:  Sioh-Yang Tan; Ben Roediger; Wolfgang Weninger
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

Review 6.  Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues.

Authors:  D Sichien; B N Lambrecht; M Guilliams; C L Scott
Journal:  Mucosal Immunol       Date:  2017-02-15       Impact factor: 7.313

7.  Distinct functions of CXCR4, CCR2, and CX3CR1 direct dendritic cell precursors from the bone marrow to the lung.

Authors:  Hideki Nakano; Miranda R Lyons-Cohen; Gregory S Whitehead; Keiko Nakano; Donald N Cook
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

8.  Complement receptor C5aR1/CD88 and dipeptidyl peptidase-4/CD26 define distinct hematopoietic lineages of dendritic cells.

Authors:  Hideki Nakano; Timothy P Moran; Keiko Nakano; Kevin E Gerrish; Carl D Bortner; Donald N Cook
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

9.  Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.

Authors:  Jamie C Fox; Takashi Nakayama; Robert C Tyler; Tara L Sander; Osamu Yoshie; Brian F Volkman
Journal:  Cytokine       Date:  2014-12-11       Impact factor: 3.861

Review 10.  Antigen presentation by Langerhans cells.

Authors:  Botond Z Igyártó; Daniel H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-12-12       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.